期刊文献+

Establishment of Hypoglycemic Agent Screening Method Based on Human Glucokinase 被引量:1

Establishment of Hypoglycemic Agent Screening Method Based on Human Glucokinase
下载PDF
导出
摘要 Objective To establish a reliable platform for screening glucokinase activators (GKAs) in vitro. Methods Pancreatic glucokinase (PGK) protein expressed in a prokaryotic expression system as a histidine-tagged fusion protein from Homo sapiens was produced. Then, response surface methodology (RSM) was used to optimize the microplate-based GKA screening platform. In the f'trst step of optimization with Plackett-Burman design (PBD), initial pH, reaction time and MgC12 were found to be important factors affecting the activity ratio of GKA (RO-28-1675) significantly. In the second step, a 23 full factorial central composite design (CCD) and RSM were applied to the optimal condition determination of each significant variable. A second-order polynomial was determined by a multiple regression analysis of the experimental data. Results The following optimal values for the critical factors were obtained: initial pH 0 (7.0), reaction time-0.63 (13.7 min) and MgC12 0.11 (2.11 mmol/L) with a predicted value of the maximum activity ratio of 34.1%. Conclusion Under the optimal conditions, the practical activity ratio is 34.8%. The determination coefficient (R2) is 0.9442, ensuring adequate credibility of the model. LLAE3, extracted from Folium nelumbinis in our laboratory, has prominently activated effects on PGK. Objective To establish a reliable platform for screening glucokinase activators (GKAs) in vitro. Methods Pancreatic glucokinase (PGK) protein expressed in a prokaryotic expression system as a histidine-tagged fusion protein from Homo sapiens was produced. Then, response surface methodology (RSM) was used to optimize the microplate-based GKA screening platform. In the f'trst step of optimization with Plackett-Burman design (PBD), initial pH, reaction time and MgC12 were found to be important factors affecting the activity ratio of GKA (RO-28-1675) significantly. In the second step, a 23 full factorial central composite design (CCD) and RSM were applied to the optimal condition determination of each significant variable. A second-order polynomial was determined by a multiple regression analysis of the experimental data. Results The following optimal values for the critical factors were obtained: initial pH 0 (7.0), reaction time-0.63 (13.7 min) and MgC12 0.11 (2.11 mmol/L) with a predicted value of the maximum activity ratio of 34.1%. Conclusion Under the optimal conditions, the practical activity ratio is 34.8%. The determination coefficient (R2) is 0.9442, ensuring adequate credibility of the model. LLAE3, extracted from Folium nelumbinis in our laboratory, has prominently activated effects on PGK.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2009年第1期62-69,共8页 生物医学与环境科学(英文版)
基金 supported by the Program for Changjiang Scholars and Innovative Research Team in University,PCSERT(No.IRT0540).
关键词 Screening mothod Human pancreatic glucokinase Protein expression Glucokinase activators Response surfacemethodology Screening mothod Human pancreatic glucokinase Protein expression Glucokinase activators Response surfacemethodology
  • 相关文献

参考文献1

二级参考文献15

  • 1Zimmet P,Alberti KG,Shaw J.Global and societal implications of the diabetes epidemic[J].Nature,2001,414:782-787.
  • 2Hadi AH,Tschopl MH,Cushman SW.Two birds with one stone:novel glucokinase activator stimulates glucoseinduced pancreatic insulin secretion and augments hepatic glucose metabolism[J].Mol Interv,2003,3:367-370.
  • 3Kamata K,Mitsuya M,Nishimura T,et al.Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase[J].Structure,2004,12:429-438.
  • 4Couzin J.Drug deals diabetes a one-two punch[J].Science,2003,301:290.
  • 5Matschinsky FM.Regulation of pancreatic β-cell glucokinase[J].Diabetes,2002,51:S394-S404.
  • 6Zelent D,Najafi H,Odili S,et al.Glucokinase and glucose homeostasis:proven concepts and new ideas[J].Biochem Soc Trans,2005,33:306 -310.
  • 7Shiota M,Postic C,Fujimoto Y,et al.Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes[J].Diabetes,2001,50:622-629.
  • 8Gloyn AL,Noordam K,Willemsen MAAP,et al.Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations[J].Diabetes,2003,52:2433 -2440.
  • 9Moore MC,Davis SN,Mann SL,et al.Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes[J].Diabetes Care,2001,24:1882-1887.
  • 10Slosberg ED,Desai UJ,Fanelli B,et al.Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein[J].Diabetes,2001,50:1813-1820.

共引文献8

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部